On-Demand | Neuropsychotropic Drug Therapy 2021: New Medications in Movement Disorders
New Medications in Movement Disorders
Shu-Ching Hu, MD, PhD
Movement Disorder Neurologist, Associate Professor of Neurology, University of Washington, Seattle
Objectives for Learning Outcomes
At the conclusion of this activity, participants will be better able to:
- Gain knowledge on the updates of Tardive Dyskinesia and its treatment.
- Describe new medications for Parkinson's Disease.
- Describe new medications for non-motor symptoms of Parkinson's Disease.
- 1.20 Contact hours
- 1.20 Pharmacology hours at the advanced practice level